Hematology/Oncology News

Endometrial hyperplasia and endometrial cancer have a low incidence for women with recurrent abnormal uterine bleeding, with predictive factors being older age, nulliparity, polyp history and shorter intervals between samplings, data show.

The addition of comprehensive metastasis-directed radiation therapy to chemotherapy improved outcomes for patients with oligometastatic pancreatic ductal adenocarcinoma, according to results of a randomized phase 2 basket trial.

Current evidence does not support lung cancer screening for never-smokers or former light smokers with a family history of lung cancer, according to a commentary in Journal of Thoracic Oncology.

During a shareholder presentation in front of more than 500 physicians in April, Debra A. Patt, MD, PhD, MBA, FASCO, asked how many in attendance used large language models like ChatGPT and Claude.

For the 2nd year in a row, HPV vaccination coverage among adolescents in the United States did not increase, according to data published Thursday by the CDC.

Two women in oncology have been named recipients of the International Gynecologic Cancer Society’s 2024 Global Humanitarian Award.

Olaparib monotherapy may be an effective treatment option for certain men with biochemically recurrent prostate cancer, according to results of a nonrandomized phase 2 trial.

Patients with cancer who received immune checkpoint inhibitors rarely developed cardiovascular adverse events, according to results of a systematic review and meta-analysis.

Exposure of certain cardiac structures to radiation during treatment of surgically inoperable or unresectable non-small cell lung cancer was associated with increased arrhythmia risk, researchers reported.

In this special 100th episode, host Shikha Jain, MD, speaks with her father, Krishna Jain, MD, about work-life balance pertaining to private practice, improving a fragmented health care system and more.